查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827395

手術器材市場（依產品、應用、技術、最終用戶、材料、便攜性和分銷）－2025-2032 年全球預測

Surgical Devices Market by Product, Application, Technology, End User, Material, Portability, Distribution - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，手術器械市場規模將成長至 303.5 億美元，複合年成長率為 7.97%。

主要市場統計數據
基準年2024年 164.2億美元
預計2025年 177.1億美元
預測年份：2032年 303.5億美元
複合年成長率（%） 7.97%

權威介紹，概述手術器械市場的範圍、目標和策略相關性，供企業決策者參考

外科器械領域正處於快速變化的臨床需求、快速的技術進步和複雜的全球供應網路的交匯點。報告的引言將引導高階主管讀者了解影響每個裝置類別產品開發、應用路徑和競爭定位的關鍵因素。報告還說明了調查方法，並為負責採購、調查方法優先順序確定和商業策略的高階領導者闡明了用例。

引言首先從臨床需求入手，將不斷發展的醫療標準和人口壓力點與器械製造商和醫療系統的創新重點聯繫起來。然後，引言轉向監管和報銷格局，重點是闡述政策變化和付款人預期如何改變商業化軌跡。最後，引言重點探討了製造地決策與物流彈性之間的相互作用，為後續探討細分市場、區域動態和企業級策略的章節奠定了基準。本指南旨在幫助讀者以務實的思維方式解讀證據，並將這些見解應用於他們的近期規劃週期。

技術、監管和市場力量如何快速再形成外科護理並重新定義跨裝置類別的競爭優勢

近年來，變革性變革加速了外科醫療服務和器材研發的步伐。微創手術和機器人輔助技術的進步不斷重塑臨床路徑，縮短了病患復原時間，並擴大了門診手術的可行性。同時，基於能量的平台和精準治療方法日趨成熟，使得更有針對性的組織相互作用成為可能，並擴大了先前僅限於急性護理的器械的治療範圍。

同時，供應鏈彈性和製造敏捷性已成為策略規劃的重中之重。製造商現在優先考慮靈活的生產線和雙重採購，以減少中斷。監管和合規格局也在發生變化，監管機構越來越重視真實世界證據和上市後監管，將其作為核准和生命週期管理流程的一部分。這些監管動態既帶來了摩擦，也帶來了機會。透過使臨床證據產生與監管預期一致，企業可​​以加快商業化進程並減少報銷摩擦。

最後，競爭架構正從單一產品轉向生態系統。醫療技術、軟體和服務領域的夥伴關係創造了捆綁產品，提供超越產品規格的臨床和營運價值。隨著支付方和醫療服務提供者對可證明的療效和成本效益的要求越來越高，投資於綜合護理解決方案和數據主導價值提案的公司將在採購談判中佔據差異化優勢。

評估 2025 年美國關稅對手術器械供應鏈、籌資策略和臨床夥伴關係關係的累積影響

2025年美國關稅政策的變化為本已複雜的全球供應環境帶來了新的變數，改變了零件採購、製造地決策和跨境庫存策略的經濟性。關稅促使企業更加重視供應鏈設計方案，並促使企業採取短期戰術性應對措施，例如重新調整採購優先順序、提高庫存緩衝以及重新協商供應商合約以抵消成本上漲。從長遠來看，這些調整將影響資本配置決策以及企業選擇投資製造產能的領域。

除了直接的成本影響外，關稅變化還影響了策略夥伴關係和臨床合作。醫療保健提供者和醫療設備製造商重新評估了其供應商關係，以確保關鍵耗材的連續性並降低關稅波動的影響。這導致人們對國內採購零件和其他區域供應商的興趣日益濃厚。對供應鏈可視性和分析的投資也在加速成長。

最後，關稅環境促使人們重新關注可製造性和材料選擇，從而減少對關稅敏感型投入的依賴。醫療器材製造商開始檢驗替代材料，並在臨床可行的情況下調整產品結構。這種累積效應表明，貿易政策如何透過採購慣例、臨床供應可靠性和長期創新策略產生連鎖效應，從而鼓勵在醫療器材的整個生命週期中重新平衡風險和韌性考量。

策略性細分洞察揭示了影響採用模式的產品、應用、技術、最終用戶、材料、便攜性和分銷動態

了解市場區隔對於制定產品策略和商業化計劃至關重要。依產品類型，市場分析包括內視鏡、能量型設備、手術植入、手術器械和手術機器人。在能量型設備中，分析進一步區分了電外科、射頻和超音波技術，反映了它們的臨床用例和監管途徑。手術植入分為心血管、牙科、神經和整形外科子領域，每個領域都有各自的臨床證據要求和植入工作流程。手術器械分為通路器械、內視鏡和通用器械，每種器械都會影響滅菌通訊協定、一次性策略和臨床醫生培訓需求。

按應用領域，我們追蹤心血管、一般外科、婦科、神經外科、整形外科和泌尿系統等領域的器械與適應症的交叉，將臨床結果需求與採用時機和購買行為聯繫起來。按技術領域，我們將重點放在高強度聚焦超音波、雷射手術、微創手術和開放性手術。微創手術類別進一步細分為內視鏡、腹腔鏡和機器人輔助技術，這是一個重要的區別，因為每種途徑都需要不同的資金、手術人員和醫療保健提供者的培訓投入。

從最終用戶的角度來看，本研究評估了門診手術中心、診所、醫院和專科手術中心的需求動態，並認知到醫療保健環境會影響購買週期、消毒基礎設施需求和報銷情況。材料也很重要。基於材料，設備和植入將從複合材料、聚合物、不銹鋼和鈦合金等選項中進行選擇，這些選項會影響設備的壽命、生物相容性考量和成本結構。最後，基於便攜性，市場區分了攜帶式和固定式解決方案。基於分銷，分析考慮了直銷、經銷商和線上銷售管道。這種分層細分提供了將產品架構與臨床工作流程、採購行為和管道經濟聯繫起來的細緻入微的視圖。

區域資訊重點在於全球主要市場和樞紐的需求促進因素、法規環境、供應鏈彈性和創新熱點

區域動態決定了技術的傳播方式以及公司投資的優先順序。在美洲，需求模式反映出私人醫療網路與大型公共醫療系統的集中，這些系統強調基於價值的採購和縮短病患住院時間。這種環境推動了人們對微創、可移動設備的有趣，這些設備可以減少住院時間和總費用。該地區的監管途徑既強調安全性，也強調實際性能。因此，早期採用的公司通常依靠臨床試驗和健康經濟證據的組合來說服大型醫療機構接受其價值提案。

歐洲、中東和非洲地區管理體制、採購框架和醫療資金籌措模式的差異性，既帶來了複雜性，也帶來了機會。報銷體系的片段化需要就臨床和經濟價值進行區域性討論。供應鏈的韌性仍然是全部區域的首要任務，製造商經常採用針對特定地區的製造和分銷策略，以在遵守法規的同時保持價格競爭力。

亞太市場以其在特定都市區的快速技術應用、對手術機器人和微創平台的積極投資以及不斷成長的國內製造能力而聞名。雖然技術應用的速度因當地臨床醫生的培訓能力和資金籌措模式而異，但該地區總體而言為擴充性的製造策略和夥伴關係關係提供了肥沃的土壤，這些策略和合作夥伴關係既針對高容量城市中心，也針對不斷擴張的次市場。區域領導者必須市場開發方法與當地採購促進因素、監管預期和臨床人員的實際情況一致，同時保持一致的全球產品和證據策略。

有關主要醫療設備製造商的產品系列、夥伴關係、製造地和投資趨勢的全面競爭情報

企業級洞察，重點在於主要企業如何將策略轉化為產品組合決策、合作夥伴選擇和營運執行。頂級競爭對手專注於打造端到端解決方案，將設備、服務、軟體和培訓相結合，以確保臨床療效並滿足醫院品質目標。許多公司正在從單一產品競爭轉向建構平台，透過耗材、資訊服務和特定流程產品實現持續的收益流。

策略聯盟和併購持續重塑企業能力版圖，中型市場公司往往成為大型公司收購的創新引擎，以加速進入相關技術領域。對於尋求限制單位成本波動並確保常用耗材供應的公司而言，最佳化生產佈局和投資自動化是關鍵的差異化因素。同時，那些投資於強大的上市後監測和真實世界證據生成的公司正獲得越來越多來自支付方和醫療系統的支持。

最後，商業模式正在不斷發展。直銷將繼續在高接觸、資本密集領域發揮關鍵作用，而經銷商和數位通路將擴大低價或消費品驅動型產品線的覆蓋範圍。企業能否根據客戶偏好調整銷售模式（例如，選擇門診中心或三級醫院）將影響採用速度和長期客戶滲透率。這些趨勢凸顯了對產品組合管理、營運韌性和客戶參與一體化方法的必要性。

為行業領導者提供切實可行的建議，優先考慮投資和夥伴關係，以加速採用安全高效的外科手術創新

領導者應優先考慮增強韌性並釋放臨床和商業潛力的行動。首先，將產品開發與明確的臨床路徑和報銷證據需求相結合，確保新產品的上市直接解決醫療服務提供者的痛點並滿足付款人閾值。儘早投資上市後數據收集，將其作為臨床開發的重要組成部分，以縮短從核准到醫院採用的時間。其次，透過重新評估供應鏈架構、實現供應商多元化、創建區域製造選項以及提高二級和三級採購的透明度，降低關稅和地緣政治風險。這些措施可以降低營運風險並保障流程的連續性。

第三，我們將在技術、軟體和服務領域建立夥伴關係，打造能夠帶來可衡量成果和營運效率的捆綁解決方案。這些合作關係不僅將提升我們的競爭地位，還將提高客戶的轉換成本。第四，我們將制定適合醫療保健環境的商業化策略，專注於資本密集型醫院領域的直銷，並利用門診和耗材市場的經銷商和數位管道。最後，我們將實施適應性定價和合約模式，以反映基於價值的採購趨勢，從而能夠更靈活地與付款人和大型醫療機構網路互動。

總的來說，這些建議在風險緩解和成長心態之間取得了平衡，為領導者提供了優先投資、建立策略聯盟和實施證據生成以支持永續臨床應用的現實藍圖。

概述資料來源、相關人員訪談、檢驗程序和研究限制的調查方法，以確保嚴格的證據綜合

調查方法將系統性的二次研究與一手相關人員訪談和結構化檢驗相結合，以產生切實可行的見解。二次研究的輸入包括監管備案文件、同行評審的臨床文獻、器械標籤文件和上市公司備案文件，以確定基準技術、材料和器械使用特性。一手研究包括對臨床醫生、供應鏈和採購主管、監管專家和行業策略專家的訪談，以了解現實世界中的應用障礙、採購偏好和未滿足的臨床需求。

本研究採用的分析架構包括價值鏈圖譜繪製、基於情境的供應鏈壓力測試、以及比較產品能力評估。在適當情況下，我們使用了證據三角檢定來檢驗關於臨床表現、生產影響和商業性吸引力的聲明。該調查方法也揭示了一些局限性，例如報銷途徑的地區差異以及影響採用時機的臨床醫生培訓項目的差異。為了解決這些局限性，本研究報告了定性判斷的置信區間，並重點介紹了建議進行局部檢驗的案例。

總體而言，這種結構化方法可確保研究結果由多個數據流和相關人員的觀點提供資訊，並提供觀察結果、支持證據和所呈現的結論之間的可追溯性，從而支持內部戰略討論和向外部相關人員的展示。

結論性綜合強調了技術、監管和經濟趨勢對領導者塑造其手術器械組合的策略影響

結論部分總結了報告為高階主管在技術進步和供應鏈日益複雜化的環境中提供的關鍵啟示。微創手術和基於能量的平台的創新持續重塑臨床工作流程，而監管和採購壓力則凸顯了可證明的成果和成本效益的重要性。供應鏈和貿易政策的變化迫使企業重新評估籌資策略，並投資於製造靈活性和視覺性。

綜上所述，這些動態有利於那些擁有有效策略的公司，這些策略將臨床差異化與營運韌性相結合，並為付款人和醫療保健提供者帶來令人信服的成果。策略夥伴關係、有針對性的資本配置以及靈活的商業化模式將決定哪些公司將在醫療保健領域獲得持續的採用。因此，領導者應利用報告的細分和區域洞察，優先考慮那些既符合近期營運需求，又符合長期投資組合目標的舉措。

這意味著，將產品設計、供應鏈策略和臨床證據產生結合的公司最有能力將創新轉化為持久的臨床和商業性影響。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 人工智慧驅動的影像引導系統快速擴展，用於即時術中決策支持
  • 一次性手術器械的需求不斷增加，以降低交叉污染的風險
  • 擴增實境疊加技術可提高腹腔鏡和內視鏡手術的精確度
  • 將無線遠端監控感測器整合到手術工具中，用於預防性維護警報
  • 開發模組化機械臂，允許在複雜過程中靈活地進行多像限訪問
  • 可攜式消毒裝置的出現，可用於資源有限的環境中的按需器械消毒
  • 增加生物可吸收植入裝置的使用，以消除二次移除手術的需要

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第 8 章：外科手術器械市場（按產品）

  • 內視鏡檢查
  • 基於能源的設備
    • 用於電外科手術
    • 射頻
    • 超音波
  • 外科植入
    • 心血管系統
    • 牙科
    • 神經系統
    • 整形外科
  • 手術器械
    • 存取裝置
    • 內視鏡檢查
    • 一般的
  • 手術機器人

第9章 手術器械市場（依應用）

  • 心血管系統
  • 一般的
  • 婦科
  • 神經系統
  • 整形外科
  • 泌尿系統

第10章 手術器械市場（依技術）

  • 高強度聚焦超音波
  • 雷射手術
  • 微創
    • 內視鏡檢查
    • 腹腔鏡
    • 機器人協助
  • 開放性手術

第 11 章。手術器械市場（按最終用戶分類）

  • 門診手術中心
  • 診所
  • 醫院
  • 專科手術中心

第 12 章：手術器械市場（按材料）

  • 合成的
  • 聚合物
  • 不銹鋼
  • 鈦

第 13 章手術設備市場：便攜性

  • 可攜式的
  • 固定式

第 14 章。手術器械市場（按分佈）

  • 直銷
  • 經銷商
  • 網上銷售

第 15 章。按地區分類的手術器械市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 16 章。手術器材市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 17 章。按國家/地區分類的手術器械市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Medtronic plc
    • Johnson & Johnson
    • B. Braun Melsungen AG
    • Stryker Corporation
    • Zimmer Biomet Holdings, Inc.
    • Baxter International Inc.
    • Boston Scientific Corporation
    • Smith & Nephew plc
    • Siemens Healthineers AG
    • Intuitive Surgical, Inc.
Product Code: MRR-434CCDA04F06

The Surgical Devices Market is projected to grow by USD 30.35 billion at a CAGR of 7.97% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 16.42 billion
Estimated Year [2025] USD 17.71 billion
Forecast Year [2032] USD 30.35 billion
CAGR (%) 7.97%

An authoritative introduction outlining the scope, objectives, and strategic relevance of the surgical devices landscape for executive decision-makers

The surgical devices domain sits at the intersection of fast-moving clinical need, rapid technological advancement, and complex global supply networks. This report's introduction orients executive readers to the principal forces shaping product development, adoption pathways, and competitive positioning across device categories. It frames the core research questions, outlines the methodological approach, and clarifies the practical use cases for senior leaders responsible for procurement, R&D prioritization, and commercial strategy.

Beginning with clinical imperatives, the introduction connects evolving standards of care and demographic pressure points to the innovation priorities of device manufacturers and health systems. It then transitions to the regulatory and reimbursement context, emphasizing how policy shifts and payer expectations alter commercialization pathways. Finally, the introduction highlights the interplay between manufacturing footprint decisions and logistical resilience, establishing a baseline for later sections that explore segmentation, regional dynamics, and company-level strategies. This orientation prepares readers to interpret the evidence with an operational mindset and to apply the insights to near-term planning cycles.

How rapid technological, regulatory, and market forces are reshaping surgical care delivery and redefining competitive advantage across device categories

Over the last several years, transformative shifts have accelerated the pace at which surgical care is delivered and devices are developed. Advances in minimally invasive and robotic-assisted techniques continue to redefine clinical pathways by reducing patient recovery time and expanding outpatient procedure feasibility. At the same time, energy-based platforms and precision modalities have matured, enabling more targeted tissue interaction and broadening the therapeutic footprint of devices previously confined to acute settings.

Concurrently, supply chain resilience and manufacturing agility have moved to the forefront of strategic planning. Manufacturers now prioritize flexible production lines and dual-source procurement to mitigate disruptions. Regulatory and compliance landscapes have also adapted, with regulators increasingly emphasizing real-world evidence and post-market surveillance as part of approval and lifecycle management processes. These regulatory dynamics create both friction and opportunity: companies that align clinical evidence generation with regulatory expectations can shorten commercialization timelines and reduce reimbursement friction.

Finally, the competitive architecture has shifted toward ecosystems rather than single-product plays. Partnerships across medtech, software, and services create bundled offerings that deliver clinical and operational value beyond product specifications. As payers and providers demand demonstrable outcomes and cost-effectiveness, companies that invest in integrated care solutions and data-driven value propositions will secure differentiated positions in procurement conversations.

Assessing the cumulative impact of United States tariffs in 2025 on supply chains, procurement strategies and clinical partnerships in surgical devices

United States tariff policy changes in 2025 introduced a new variable into an already complex global supply environment, altering the economics of component sourcing, manufacturing location decisions, and cross-border inventory strategies. Tariffs increased the impetus for companies to examine supply chain design choices, prompting near-term tactical responses such as reprioritizing procurement, raising inventory buffers, and renegotiating supplier contracts to offset incremental costs. Over time, these adjustments influence capital allocation decisions and where companies choose to invest in manufacturing capacity.

In addition to direct cost impacts, tariff shifts affected strategic partnerships and clinical collaborations. Providers and device manufacturers reassessed vendor relationships to ensure continuity of critical consumables and to reduce exposure to tariff volatility. This led to greater interest in domestically sourced components or alternate regional suppliers. Investment in supply chain visibility and analytics accelerated, as leaders sought to quantify exposure and model scenario impacts on product availability for elective and urgent procedures.

Finally, the tariff environment contributed to a renewed focus on design for manufacturability and material choices that reduce dependence on tariff-sensitive inputs. Organizations moved to validate alternative materials and to adapt product architectures where clinically feasible. These cumulative responses demonstrate how trade policy can cascade through procurement practices, clinical supply reliability, and long-term innovation strategies, prompting a rebalancing of risk and resilience considerations across the device lifecycle.

Strategic segmentation insights revealing product, application, technology, end user, material, portability and distribution dynamics shaping adoption patterns

Understanding segmentation is essential for shaping product strategy and commercialization plans. Based on Product, market analysis includes Endoscopes, Energy-Based Devices, Surgical Implants, Surgical Instruments, and Surgical Robots. Within Energy-Based Devices, the analysis further distinguishes Electrosurgical, Radio Frequency, and Ultrasound technologies, reflecting distinct clinical use cases and regulatory pathways. Surgical Implants are categorized into Cardiovascular, Dental, Neurological, and Orthopedic subsegments, each governed by unique clinical evidence requirements and implantation workflows. Surgical Instruments are differentiated across Access Devices, Endoscopic, and General instrument groups, which influence sterilization protocols, disposable strategies, and clinician training demands.

When viewed Based on Application, the report tracks device intersection with Cardiovascular, General, Gynecology, Neurological, Orthopedic, and Urology indications, connecting clinical outcomes imperatives to adoption timing and purchasing behavior. Based on Technology, technologies of interest include High-Intensity Focused Ultrasound, Laser Surgery, Minimally Invasive, and Open Surgery. The Minimally Invasive category is further subdivided into Endoscopic, Laparoscopic, and Robotic Assisted techniques, an important distinction because each pathway entails different capital equipment, procedural staffing, and training investments for provider organizations.

From the end-user perspective, Based on End User, the study evaluates demand dynamics across Ambulatory Surgical Centers, Clinics, Hospitals, and Specialty Surgical Centers, recognizing that care setting influences purchasing cycles, sterilization infrastructure needs, and reimbursement contexts. Materials matter as well; Based on Material, devices and implants are examined across Composite, Polymers, Stainless Steel, and Titanium selections, which affect device longevity, biocompatibility considerations, and cost structure. Finally, Based on Portability, the market differentiates Portable versus Stationary solutions, and Based on Distribution, the analysis considers Direct Sales, Distributors, and Online Sales channels. This layered segmentation provides a nuanced view that links product architecture to clinical workflows, procurement behavior, and channel economics.

Regional intelligence highlighting demand drivers, regulatory environments, supply chain resilience, and innovation hotspots across key global markets and hubs

Regional dynamics materially shape how technologies diffuse and how companies prioritize investments. In the Americas, demand patterns reflect a concentrated private provider network alongside large public health systems that emphasize value-based procurement and shorter patient stays. This environment drives interest in minimally invasive and ambulatory-capable devices that reduce length of stay and total episode cost. Regulatory pathways in the region emphasize both safety and real-world performance; as a result, early adopters often couple clinical pilots with health-economic evidence to convince larger providers of the value proposition.

In Europe, Middle East & Africa, heterogeneous regulatory regimes, procurement frameworks, and healthcare financing models create both complexity and opportunity. Fragmented reimbursement landscapes mean that localized clinical and economic value arguments prove necessary. Supply chain resilience remains a priority across the region, and manufacturers frequently adopt region-specific manufacturing or distribution strategies to maintain competitive pricing while meeting regulatory compliance.

Asia-Pacific markets are notable for rapid technology uptake in select urban centers, aggressive investment in surgical robotics and minimally invasive platforms, and growing domestic manufacturing capabilities. The pace of adoption varies with local clinician training capacity and funding models, but the region collectively represents fertile ground for scalable manufacturing strategies and partnerships that target both high-volume urban centers and expanding secondary markets. Across regions, leaders must tailor go-to-market approaches to local procurement drivers, regulatory expectations, and clinical workforce realities while maintaining a coherent global product and evidence strategy.

Competitive intelligence synthesizing product portfolios, partnerships, manufacturing footprints and investment trends among leading device manufacturers

Company-level insights focus on how leading organizations translate strategy into portfolio decisions, partner selection, and operational execution. Top competitors concentrate on building end-to-end solutions that combine devices with services, software, and training to lock in clinical outcomes and align with hospital quality goals. Many firms have moved beyond single-product competition to create platforms that enable recurring revenue streams through consumables, data services, and procedure-specific offerings.

Strategic alliances and M&A activity continue to reconfigure capability maps, with mid-sized firms often acting as innovation engines that larger players acquire to accelerate entry into adjacent technology areas. Manufacturing footprint optimization and investments in automation have become important differentiators for players seeking to reduce per-unit cost volatility and to maintain supply assurance for high-use consumables. Meanwhile, companies that demonstrate robust post-market surveillance and that invest in real-world evidence generation find improved receptivity among payers and health systems.

Finally, commercial models are evolving. Direct sales remain key in high-touch, capital-intensive segments, while distributors and digital channels expand access for lower-cost or consumable-driven product lines. The ability of a company to align its sales model to the customer setting-ambulatory center versus tertiary hospital, for example-affects adoption speed and long-term account penetration. These trends underscore the need for an integrated approach to portfolio management, operational resilience, and customer engagement.

Actionable recommendations for industry leaders to prioritize investments and partnerships that accelerate safe and efficient surgical innovation adoption

Leaders should prioritize actions that enhance resilience while unlocking clinical and commercial upside. First, align product development with clearly defined clinical pathways and reimbursement evidence needs so that new launches directly address provider pain points and payer thresholds. Invest early in post-market data collection as an integral part of clinical development to shorten the time from approval to widespread hospital adoption. Second, re-evaluate supply chain architectures to reduce tariff and geopolitical exposure by diversifying suppliers, creating regional manufacturing options, and increasing visibility into tier-two and tier-three sourcing. These steps will reduce operational risk and protect procedure continuity.

Third, cultivate partnerships across technology, software, and services to build bundled solutions that deliver measurable outcomes and operational efficiencies. Such collaborations not only improve competitiveness but also create higher switching costs for customers. Fourth, tailor commercialization strategies to care settings by deploying direct sales in capital-intensive hospital segments while leveraging distributors and digital channels for ambulatory and consumable-driven markets. Finally, embed adaptive pricing and contracting approaches that reflect value-based procurement trends, enabling more flexible engagement with payers and large provider networks.

Taken together, these recommendations balance risk mitigation with growth orientation, providing leaders with a pragmatic roadmap for prioritizing investments, forging strategic alliances, and operationalizing evidence generation to support sustainable clinical adoption.

Research methodology outlining data sources, stakeholder interviews, validation procedures and study limitations to ensure rigorous evidence synthesis

The research methodology combines systematic secondary research with primary stakeholder engagement and structured validation to produce actionable findings. Secondary inputs included regulatory filings, peer-reviewed clinical literature, device labeling documents, and public company filings to establish baseline technology, material, and device usage characteristics. Primary research included interviews with clinicians, supply chain and procurement executives, regulatory specialists, and industry strategists to capture real-world adoption barriers, procurement preferences, and unmet clinical needs.

Analytical frameworks applied in the study include value chain mapping, scenario-based supply chain stress testing, and comparative product capability assessment. Where appropriate, evidence triangulation validated claims about clinical performance, manufacturing implications, and commercial traction. The methodology also documents limitations, including variability across local reimbursement pathways and differences in clinician training programs that affect adoption timing. To address these constraints, the study reports confidence bounds around qualitative judgments and specifies instances where local validation is recommended.

Overall, this structured approach ensures the findings are grounded in multiple data streams and stakeholder perspectives. It also creates traceability between observations, underlying evidence, and the conclusions presented, supporting both internal strategy discussions and external stakeholder briefings.

Conclusive synthesis articulating the strategic implications of technological, regulatory and economic trends for leaders shaping surgical device portfolios

The conclusion synthesizes the report's principal takeaways for executives seeking to navigate an environment of technological advance and supply chain complexity. Technological innovation in minimally invasive procedures and energy-based platforms continues to reshape clinical workflows, while regulatory and procurement pressures emphasize the need for demonstrable outcomes and cost-effectiveness. Supply chain and trade policy shifts compel organizations to reassess sourcing strategies and to invest in manufacturing flexibility and visibility.

Taken together, these dynamics favor companies that can combine clinical differentiation with operational resilience and who can present compelling, evidence-based value propositions to payers and providers. Strategic partnerships, targeted capital allocation, and adaptable commercialization models will determine which organizations capture sustained adoption across care settings. Leaders should therefore apply the report's segmentation and regional insights to prioritize initiatives that align with both near-term operational needs and long-term portfolio ambitions.

In sum, the surgical devices landscape rewards integrated thinking: those that coordinate product design, supply chain strategy, and clinical evidence generation will be best positioned to convert innovation into lasting clinical and commercial impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rapid expansion of AI-driven image guidance systems for real-time intraoperative decision support
  • 5.2. Growing demand for single-use disposable surgical instruments to reduce cross-contamination risks
  • 5.3. Adoption of augmented reality overlays in laparoscopic and endoscopic surgery for improved precision
  • 5.4. Integration of wireless remote monitoring sensors in surgical tools for proactive maintenance alerts
  • 5.5. Development of modular robotic arms enabling flexible multi-quadrant access during complex procedures
  • 5.6. Emergence of portable point-of-care sterilization units for on-demand instrument decontamination in low-resource settings
  • 5.7. Rising utilization of bioresorbable implantable devices to eliminate the need for secondary removal surgeries

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Devices Market, by Product

  • 8.1. Endoscopes
  • 8.2. Energy-Based Devices
    • 8.2.1. Electrosurgical
    • 8.2.2. Radio Frequency
    • 8.2.3. Ultrasound
  • 8.3. Surgical Implants
    • 8.3.1. Cardiovascular
    • 8.3.2. Dental
    • 8.3.3. Neurological
    • 8.3.4. Orthopedic
  • 8.4. Surgical Instruments
    • 8.4.1. Access Devices
    • 8.4.2. Endoscopic
    • 8.4.3. General
  • 8.5. Surgical Robots

9. Surgical Devices Market, by Application

  • 9.1. Cardiovascular
  • 9.2. General
  • 9.3. Gynecology
  • 9.4. Neurological
  • 9.5. Orthopedic
  • 9.6. Urology

10. Surgical Devices Market, by Technology

  • 10.1. High-Intensity Focused Ultrasound
  • 10.2. Laser Surgery
  • 10.3. Minimally Invasive
    • 10.3.1. Endoscopic
    • 10.3.2. Laparoscopic
    • 10.3.3. Robotic Assisted
  • 10.4. Open Surgery

11. Surgical Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals
  • 11.4. Specialty Surgical Centers

12. Surgical Devices Market, by Material

  • 12.1. Composite
  • 12.2. Polymers
  • 12.3. Stainless Steel
  • 12.4. Titanium

13. Surgical Devices Market, by Portability

  • 13.1. Portable
  • 13.2. Stationary

14. Surgical Devices Market, by Distribution

  • 14.1. Direct Sales
  • 14.2. Distributors
  • 14.3. Online Sales

15. Surgical Devices Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Surgical Devices Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Surgical Devices Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Medtronic plc
    • 18.3.2. Johnson & Johnson
    • 18.3.3. B. Braun Melsungen AG
    • 18.3.4. Stryker Corporation
    • 18.3.5. Zimmer Biomet Holdings, Inc.
    • 18.3.6. Baxter International Inc.
    • 18.3.7. Boston Scientific Corporation
    • 18.3.8. Smith & Nephew plc
    • 18.3.9. Siemens Healthineers AG
    • 18.3.10. Intuitive Surgical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SURGICAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL SURGICAL DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS SURGICAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. SURGICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. SURGICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SURGICAL DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SURGICAL DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DENTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DENTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DENTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DENTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DENTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ACCESS DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ACCESS DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ACCESS DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ACCESS DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ACCESS DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ACCESS DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GYNECOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GYNECOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GYNECOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GYNECOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GYNECOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SURGICAL DEVICES MARKET SIZE, BY UROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SURGICAL DEVICES MARKET SIZE, BY UROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SURGICAL DEVICES MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SURGICAL DEVICES MARKET SIZE, BY UROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SURGICAL DEVICES MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SURGICAL DEVICES MARKET SIZE, BY UROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LASER SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LASER SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LASER SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LASER SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LASER SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LASER SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL SURGICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL SURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL SURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL SURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL SURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL SURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL SURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SPECIALTY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SPECIALTY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SPECIALTY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SPECIALTY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SPECIALTY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SPECIALTY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COMPOSITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COMPOSITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COMPOSITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COMPOSITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COMPOSITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COMPOSITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL SURGICAL DEVICES MARKET SIZE, BY POLYMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL SURGICAL DEVICES MARKET SIZE, BY POLYMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL SURGICAL DEVICES MARKET SIZE, BY POLYMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL SURGICAL DEVICES MARKET SIZE, BY POLYMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL SURGICAL DEVICES MARKET SIZE, BY POLYMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL SURGICAL DEVICES MARKET SIZE, BY POLYMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TITANIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TITANIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TITANIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TITANIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL SURGICAL DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL SURGICAL DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS SURGICAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS SURGICAL DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 289. AMERICAS SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 290. AMERICAS SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 291. AMERICAS SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. AMERICAS SURGICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 293. AMERICAS SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 294. AMERICAS SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 295. AMERICAS SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 296. AMERICAS SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 297. AMERICAS SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2024 (USD MILLION)
  • TABLE 298. AMERICAS SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 306. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 308. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 309. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 312. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 313. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 314. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 315. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 317. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 318. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 319. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 320. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 321. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2024 (USD MILLION)
  • TABLE 322. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2025-2032 (USD MILLION)
  • TABLE 323. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 324. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 325. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 326. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 327. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 328. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 329. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 330. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 331. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 332. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 333. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 334. LATIN AMERICA SURGICAL DEVICE